Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
45 Cards in this Set
- Front
- Back
Crosstalk of JAK signaling pway and other pways
|
-JAK xtalks w/ MAP Kinase pway thru Ras and Raf
-JAK has substrates besides STATs -JAK can associate w/ other non-receptor Tyr kinases -STATs can interact w/ other txn factors |
|
Tyr Kinase Steps
|
1. Ligand->homodimer->auto(P)@Tyr
2. (P)Tyr is docking site for GRB2 adaptor proteins 3. GRB2 complexes w/SOS->facilitates RasGDP to RasGTP (slow, add GAP to speed up) 4. RasGTP -> Map Kinase and PI3 kinase p-ways |
|
FHC: properties
|
-Familial hypertrophic cardiomyopathy
-leading cause of sudden cardiac death in young patients -mutation in sarcomere proteins ->has to maintain higher [Ca2+] -> hypertrophy in cardiomyocytes |
|
TGFbeta/SMAD pway steps
|
1. ligand->Type II receptor
2. Type I receptor joins complex and (P) by T-II receptor 3. (P)T-I receptor (P)ates "Pathway-Restricted SMADs 4. (P) of SMADs causes dimerization w/SMAD 4->nucleus ->txn activity 5. Inhibitory SMADs (6&7) block activation of p-way restricted SMADs |
|
PI3 Kinase pathway
|
-a lipid kinase
-activated in proliferation, differentiation, cell survival and cytoskeletal reorg. -activated by Ras-independent and dependent p-ways -PI3 (P) PI lipids->become binding sites for various kinases |
|
JAK/STAT steps
|
1. cytokine binding induces receptor chains to oligomerize or reorient in preformed oligomer
2. binding of ligand and conformation change brings cytoplasmic kinases close-> (P) eachother 3. JAKs (P) Tyr residue on STATs, causing them to dissociate from receptor 4. (P)-STATs dimerize-->nucleus & bind DNA response elements |
|
Enzyme-linked receptors and roles
|
JAK/STAT plays major role in cytokine signaling for IFN-a, IFN-B, IFN-y and interleukins
|
|
IFN-a/y purposes
|
lead to antiviral response and growth restraint in a number of diff't cell types
|
|
reversibility of signaling
|
1. covalent protein modification
-(P) 2. Nucleotide exchange -GTP binding protein |
|
G protein-coupled
|
a.Ligand binding activates a G-protein, which in turn activates/inhibits other enzymes to produce second messengers (i.e. glucagons)
|
|
Receptors with enzymatic activity
|
Ligand binding activates the catalytic component of the receptor (i.e. any receptor with Ser/Thr/Tyr kinase, like insulin receptor
|
|
Receptors with enzymatic activity: examples
|
(tyrosine-kinase)-linked receptors: ligand binding stimulates formation of a dimeric receptor that interacts on cytosolic protein-tyrosine kinases (i.e. receptors for cytokines, interferons and human GF)
|
|
Mouse models: 4 types & what rely on for getting gene in
|
xgenic: nonspecific insertion
k-out, k-in, conditional: Homologous recombination |
|
Mouse models: endogenous gene
|
XG: no change
KO: disrupted KI: replaced w/ mutant CK: cond. disrupted (location, tissue, stage of life) |
|
2 actions of Gq pathway
|
PIP2->IP3 and DAG
IP3->ER->releases Calcium DAG->->PKC |
|
Cholera
|
ADP ribosylates GsAlpha subunit so that it can't hydrolyze GTP
->persistent activation |
|
Gi
|
inhibits Gs pathway
->inhibits adenylyl cyclase->inhib. cAMP |
|
actetylcholine and G proteins
|
non-canonical: beta/gamma does the work and opens the K+channel to relax heart muscle
|
|
Beta 1 receptor
|
-heart cells (among other places)
-epineph. binds beta 1 and increases HR ->give beta1 blocker to slow heart down |
|
Beta 2 receptor
|
-in lungs (w/others)
-Epi binds beta 2 receptors in lungs -> relaxes smooth muscle->bronchodilation (for asthma) |
|
Calmodulin
|
activated by binding Ca2+
-alters activity of other enzymes like Ca-calmodulin dependent protein kinase II (CaM Kinase II) |
|
CaM Kinase II
|
-when it binds Ca2+/Calmodulin complex->activates and auto(P)
->sustains itself until dephosphorylated (prolongs response->memory) |
|
Calcineurin
|
-Ser/Thr (P)tase, activated by Ca2+/Calmodulin and Ca2+ alone
-activates NFAT by removing a (P) |
|
NFAT immune response
|
-activated by Calcineurin
-drugs can block (P)tase activity of NFAT and decrease immunity (xplant patients) -drugs: CSA and FK506 |
|
FHC: drugs
|
CSA and FK506 won't help because can't maintain high enough concentrations in heart cells w/o thrashing immune systems (have a higher [NFAT])
|
|
Tyrosine Kinase Receptors: properties
|
-growth and differentiation
-xmit signal thru Ser/Thr kinases via Ras proteins |
|
Ras
|
-superfamily of GTPases
-mutated in 20-30% of cancers -Mutant Ras binds GTP but can't hydrolyze it->sustained activation of p-way |
|
Map Kinase pathway
|
1. Activated Ras->Raf Kinase (Map KKK), MEK and others
2. MapK is a Ser/Thr kinase->nucleus->(P) many proteins & xscrip. factors |
|
Members of Ras Superfamily
|
1. Rho/Rac - cytoskeleton organization
2. Rab - membrane trafficking 3. Ran - mitosis and nuclear transport |
|
Regulation of Ras Signaling
|
GAP and SOS
|
|
GAP regulating activities
|
-Ras-GTPases are slow
-GAP accelerates GTPases by 10^5 -homolog of it is RGS->used to accelerate G protein alpha subunit by 100 fold |
|
SOS regulating activities
|
-is a GEF (guanine nucleotide exchange factor)
-helps enzymes change between GTP and GDP |
|
Enzyme-linked receptors
|
Cytokines and JAK/STAT signaling
|
|
Cytokine signaling
|
-involves interleukins (ILs), interferons (IFNs) and colony stimulating factors (CSFs)
-have pleiotropy -no tyr kinase domains, but recruit PTK to (P) Tyr residues |
|
JAK-STAT general
|
cytokines bind to receptors associated with JAK family
|
|
JAK STAT pathway steps
|
1. ligand binds JAK kinase, activated by auto(P)
2. (P)Tyr residue on receptor->binding sites for STATs 3. after recuitment, STATs (P) by JAK 4. STATs leave, dimerize->nucleus->become xscrip factors |
|
STATs: definition
|
signal transducers and activators of transcription
|
|
STAT1 deficient mice
|
failed to activate genes in response to IFNalpha and IFNgamma
->high sensitivity to viral and microbial infections |
|
STAT4 deficient mice
|
had lymphocytes that were unable to fight infections
|
|
TGF beta: properties
|
-regulates developmental processes: differentiation, skeletal morphogenesis and skin formation
-binds heteromeric cell surface receptor complexes w/Ser/Thr kinases |
|
TGF beta examples
|
activins and bone morphogenic proteins (BMPs)
|
|
TGF beta receptor types
|
Type I and II
|
|
SMAD: properties
|
-located in cell
-xmits signal from extracellular TGF beta |
|
Pancreatic cancer
|
-SMAD 4 suppresses tumors
-loss of SMAD 4 results in pancreatic cancers |
|
Marfan Syndrome
|
-mutations in Type II receptors
-autosomal dominant -disorder of fibrous connective tissue -affects skeletal and cardiovascular systems |